David J. Park, MD

Articles by David J. Park, MD

A panel of 4 experts on multiple myeloma

Collaborative Education for CAR T-Cell Therapy

ByAmrita Y. Krishnan, MD,Saad Z. Usmani, MD, MBA, FACP,David J. Park, MD,Sanjay Sharma, MD

July 10th 2024

The panel concludes its discussion with insights on practices for educating health care teams on CAR T-cell therapy administration, highlighting the evolving role of advanced practice providers.

David J. Park, MD

Articles by David J. Park, MD

Collaborative Education for CAR T-Cell Therapy

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

FDA Grants Fast Track Designation to MT-125 in Glioblastoma

HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma

FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset

FDA Accepts NDA for New Nilotinib Formulation in CML